IVAs 100-lista: aktuell forskning med potential för nyttiggörande

Coronary artery disease (CAD) is the most common type of heart disease worldwide and a leading cause of death globally every year and it is predicted to remain so for the next 20 years.

“Geoint” är en lösning som sänker tröskeln till att kombinera AI med geografiska data.

The COVID-19 pandemic highlighted that crisis preparedness requires disease detection methods that are quick, scalable, and economically viable.

SVART IRIS utvecklar metoder för att med hjälp av simulering och strukturerad analys stödja konceptutvecklingen av beslutsstödsystem i tidiga faser av systemutveckling. Metodutvecklingen drivs genom fyra tillämpade fall från flygledningsarenan.

We have designed a novel robotic architecture that for the first time ever unifies multi-modalities in robotic locomotion (walking and flying), while creating an embodiment of autonomy.

We have developed a unique solution for efficient and safe sharing of infrastructure. The research combines a proven-correct algorithm that stops vehicles before a potential accident occurs, with a method for safety analysis that enables certification to relevant standards of the entire system of self-driving and manual vehicles.

Sjyst data! är ett projekt i skärningspunkten mellan juridik, teknik, affärsnytta och användarperspektiv.

Electric utilities currently rely on a reactive approach to grid management, towards the disturbances and faults that have occurred. This approach can lead to severe grid faults and high costs associated with downtime, energy loss, damaged equipment, and unscheduled maintenance.

According to the World Health Organization, cardiovascular disease is responsible for roughly one-third of all deaths worldwide each year, and based on the European Heart Network, this disease causes over 1.8 million premature deaths in EU annually, accounting for 37% of all deaths in EU.

Breast cancer is the most common cancer type globally and the incidence rate is increasing. Women in low-income countries have a noticeably lower chance for survival compared to women in high-income countries. WHO has acknowledged the need for a timely diagnosis to decrease the mortality of breast cancer.